Marinus Pharmaceuticals Inc (MRNS)
1.46
+0.05
(+3.55%)
USD |
NASDAQ |
May 01, 16:00
1.45
-0.01
(-0.68%)
After-Hours: 04:51
Marinus Pharmaceuticals Debt to Equity Ratio: 4.353 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.353 |
| September 30, 2023 | 1.329 |
| June 30, 2023 | 1.255 |
| March 31, 2023 | 0.8558 |
| December 31, 2022 | 0.6122 |
| September 30, 2022 | 0.8631 |
| June 30, 2022 | 14.65 |
| Date | Value |
|---|---|
| March 31, 2022 | 1.731 |
| December 31, 2021 | 0.763 |
| September 30, 2021 | 0.517 |
| June 30, 2021 | 0.1154 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Sep 2020
14.65
Maximum
Jun 2022
1.932
Average
0.8094
Median
Debt to Equity Ratio Benchmarks
| Ligand Pharmaceuticals Inc | 0.00 |
| Soligenix Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
| Macrogenics Inc | 0.00 |
| ADMA Biologics Inc | 0.9659 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 170.91M |
| Total Liabilities (Quarterly) | 154.14M |
| Shareholders Equity (Quarterly) | 16.76M |
| Current Ratio | 4.068 |
| Net Debt Paydown Yield | -0.07% |